UNODC: CND decision on international control of ADB-BUTINACA, alpha-PiHP and 3-methylmethcathinone enters into force

VIENNA, Austria – November 2023: The decision adopted by the Commission on Narcotic Drugs (CND) during its 66th Session, from 13 to 17 March 2023, to add ADB-BUTINACA, alpha-PiHP and 3-methylmethcathinone to Schedule II of the Convention on Psychotropic Substances of 1971 entered into force on 13 November 2023.

Brief summaries including interactive data visualisations on those three substances are accessible in the “Latest news on NPS” section.

Previously, on 17 May 2023, the decision adopted by the CND to add 2-methyl-AP-237, etazene, etonitazepyne, and protonitazene to Schedule I of the Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol,entered into force.
 

For further information please see: 

UNODC EWA newsclip: May 2023 – UNODC: CND decision on international control of 2-methyl-AP-237, etazene, etonitazepyne, protonitazene enters into force 

UNODC EWA newsclip: March 2023 – UNODC: Seven NPS “scheduled” at the 66th Session of the Commission on Narcotic Drugs 

UNODC EWA newsclip: December 2022 – WHO: World Health Organization recommends seven NPS for scheduling 

UNODC EWA newsclip: May 2023 – UNODC: Update on ADB-BUTINACA: control status, emergence, use, detection, and identification 

UNODC EWA newsclip: May 2023 – UNODC: Update on α-PiHP: control status, emergence, use, detection, and identification 

UNODC EWA newsclip: April 2023 – UNODC: Update on 3-MMC: control status, emergence, use, detection, and identification